United States
Securities and Exchange Commission
Washington, DC 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
CELGENE CORP.
(Name Of Issuer)
Common
(Title of Class of Securities)
151020104
(CUSIP Number)
Donald P. Moriarty and/or William P. Scully
c/o McGrath, Doyle & Phair
150, Broadway, Suite 1703
New York, NY 10038
Telephone: (212) 571-2300
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
12/1/97
(Date of Event which Requires
Filing of this Statement)
If the filing person has previously filed a statement of Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13-1d(b)(3) or (4), check the
following box [ ].
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of the
Act (however, see the Notes.)
SCHEDULE 13D page 2 of 4 pages
1. NAME OF REPORTING PERSON Donald P. Moriarty and/or
William P. Scully
SS OR IRS IDENTIFICATION NO. OF
THE ABOVE PERSON
2. CHECK THE APPROPRIATE BOX IF A Controls voting and dispositive (a)[x]
MEMBER OF A GROUP power for himself, his family (b)[ ]
members and a partnership in
which he and his partner are
general partners.
3. SEC USE ONLY
4. SOURCE OF FUNDS PF
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS [ ]
(IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
6. CITIZENSHIP OR PLACE OF ORGANIZATION USA
NUMBER OF 7. SOLE VOTING POWER 1,229,000
SHARES
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY
EACH 9. SOLE DISPOSITIVE POWER 1,229,000
REPORTING
PERSON WITH 10. SHARED DISPOSITIVE POWER
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH 1,229,000
REPORTING PERSON
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) [ ]
EXCLUDES CERTAIN SHARES
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 7.9853%
14. TYPE OF REPORTING PERSON IN
SCHEDULE 13D page 3 of 4 pages
Item 1. Security and Issuer.
a) Name and Address of Principal Executive Officers of Issuer:
Celegene Corp.
7 Powderhorn Drive
Warren, NJ 07059
(b) Title and class of Common Stock
Equity Securities:
Item 2. Identity and Background.
(a) Name of Person Filing Donald P. Moriarty and/or
William P. Scully
(b) State of Incorporation: N/A
(c) Principal of Business: Investment Advisor,
Twin Oaks Partners
One Main Street
Chatham, NJ 07928
(d) Address of Principal Business
and Principal Office:
c/o McGrath, Doyle & Phair
150 Broadway, # 1703
New York, NY 10038
(e) Criminal Proceedings: N/A
(f) Civil Proceedings: N/A
SCHEDULE 13D page 4 of 4 pages
Item 3. Source and Amount of Funds or other Consideration.
Personal Funds - $2,353,145 paid for additional purchases
Item 4. Purpose of Transaction.
Material acquisition for investment purposes
Item 5. Interests in Securities of the Issuer.
(a) Number of Shares 1,229,000 shares
Beneficially Owned:
Percent of Class: 7.9853%
(b) Sole Power to Vote,
Direct the Vote of, or 1,229,000 shares
Dispose of Shares:
Shared Power to Vote,
Direct the Vote of, or None
Dispose of Shares:
(c) Recent Transactions:
Investor acquired approximately an additional 0.195% of the
common shares outstanding since the last filing of Schedule
13D. However, please note that the company issued additional
shares since the last Schedule 13D filing which diluted the
investors holdings.
(d) Rights to Dividends or
Sales Proceeds: N/A
(e) Date of Cessation of Five Percent
Beneficial Ownership: N/A
Item 6. Contracts, Arrangements, Understandings
or Relationships with Respect to
Securities of the Issuer. N/A
Item 7. Material to be Filed as Exhibits. N/A
Nicholas Jacangelo, CPA
